Viser 319 bedrifter for "Pharmaceuticals"
Bedrifter
CATALYST PHARMACEUTICALS, INC.
Catalyst Pharmaceuticals is dedicated to improving the lives of patients with rare diseases. They focus on developing and commercializing innovative therapies. The company is positioned as a leader in the treatment of rare neuromuscular diseases.
VERTEX PHARMACEUTICALS INC / MA
Vertex is a global biotechnology company focused on discovering, developing, and commercializing innovative medicines. They are known for their significant advancements in treating cystic fibrosis (CF) with CFTR modulators. Vertex also has a pipeline targeting other serious diseases in areas such as pain, kidney diseases, sickle cell disease, beta thalassemia, and type 1 diabetes, positioning them as a leader in addressing unmet medical needs.
Laboratorios Farmaceuticos Rovi, S.A./ADR
ROVI is a pharmaceutical company focused on the research, development, manufacturing, and marketing of specialty pharmaceuticals. Their key products include low molecular weight heparin and biosimilars. The company has a significant international presence and a strong commitment to research and development.
Valneva SE
Valneva is a specialty vaccine company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases with unmet medical needs. They offer commercially available vaccines like a single-shot chikungunya vaccine, and boast a robust pipeline of vaccine candidates, including those against Lyme disease, Shigella, and Zika. With expertise in travel health and a commitment to innovation, Valneva aims to prevent suffering from vaccine-preventable diseases. The company has over 700 employees in six countries.
CEVA INC
Ceva is the 5th largest global animal health company, led by experienced veterinarians. They provide innovative health solutions for all animals to ensure the highest level of care and well-being. As a leading French company headquartered in France, Ceva focuses on 'One Health' and sustainable practices. Their vision emphasizes the interconnectedness of human, animal, and planetary health.
MOLECULAR PARTNERS AG
Molecular Partners is a pioneering biopharmaceutical company focused on DARPin therapeutics, a new class of custom-built drugs. They develop innovative therapies for serious diseases, including cancer. Their strategy combines in-house DARPin design and development expertise with collaborations to deliver a broad pipeline.
Harmony Biosciences Holdings, Inc.
Harmony Biosciences is a pharmaceutical company focused on developing and delivering innovative therapies for rare neurological diseases. They specialize in treatments for sleep/wake disorders, neurobehavioral conditions, and rare epilepsies. With a commitment to empathy and innovation, they aim to improve the lives of patients by addressing unmet medical needs and advancing patient-kind through novel treatments.
COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical is a biopharmaceutical company dedicated to improving the lives of individuals living with serious medical conditions. They focus on developing differentiated medications, with a strong presence in responsible pain management and neuropsychiatry, including a medicine for ADHD. Collegium is committed to building a leading, diversified portfolio and contributing to the well-being of their communities.
Xeris Biopharma Holdings, Inc.
Xeris is a biopharmaceutical company focused on developing and commercializing innovative products to improve patient lives across a range of therapies. They offer ready-to-use solutions across various therapeutic areas. The company is known for its advanced products and partnerships.
BAYER AS
Bayer er et selskap som arbeider for "Helse for alle, ingen sult". De utvikler nye legemidler og arbeider for en bedre matforsyning. I Norge fokuserer Bayer på forskning og utvikling av radioaktive farmasøytiske produkter, spesielt kreftbehandling med alfa-emitterende isotoper. De utviklet kreftmedisinen Xofigo.
Terns Pharmaceuticals, Inc.
Terns is a clinical-stage biopharmaceutical company developing superior therapies to elevate human health. They focus on small molecule medicines targeting diseases with significant unmet medical needs, particularly in oncology. Their aim is to create transformative medicines through bold innovation and clinically validated mechanisms.
PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for children and adults living with serious diseases of high unmet need. Focused on rare diseases with a patient-centric approach, PTC combines scientific expertise with groundbreaking technology. Key research areas include splicing modulation and inflammation & ferroptosis, aiming to provide broad access to life-changing treatments.
Sarepta Therapeutics, Inc.
Sarepta Therapeutics is a global biotechnology company focused on precision genetic medicine for rare diseases. They engineer RNA platforms and gene therapy to transform genetic understanding into medicine. Sarepta strives to accelerate the development of new treatments, building the world's largest gene therapy manufacturing capacity.
Septerna, Inc.
Septerna is a biotechnology company powered by its proprietary Native Complex Platform™ to develop oral small molecule therapies targeting GPCRs. The company focuses on treating patients in endocrinology, immunology and inflammation, and metabolic diseases, with a deep pipeline of product candidates.
INOVIO PHARMACEUTICALS, INC.
INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer, and infectious diseases. They are trailblazers in the DNA medicine field, working to commercialize innovative, next-generation medicines. Their focus is on innovating medicine to help save lives.
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. They focus on changing the narrative around viral skin diseases and making treatment more efficient. Their lead product, YCANTH®, is approved for the treatment of molluscum contagiosum. They are also developing VP-315 for the treatment of dermatologic oncologic conditions.
INCYTE CORP
Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies. They specialize in oncology and dermatology. The company is committed to improving patient outcomes through scientific excellence and a passion for innovation.
Editas Medicine, Inc.
Editas Medicine is a pioneering gene editing company focused on developing transformative medicines using CRISPR/Cas9 and CRISPR/Cas12a genome editing systems. They aim to discover, develop, manufacture, and commercialize precise genomic medicines for a broad range of serious diseases worldwide. The company's pipeline includes experimental medicines focused on in vivo gene editing and other innovative approaches. Editas Medicine is headquartered in Cambridge, MA, with a site in Boulder, CO.
Galecto, Inc.
Galecto develops small molecules for the treatment of severe diseases, including cancer and fibrosis. The company focuses on modulators of galectin-3 and ENL/YEATS / FLT3 to treat cancer and severe liver diseases. Galecto has a unique therapeutic platform and aims to improve patient treatments.
Amylyx Pharmaceuticals, Inc.
Amylyx is a clinical-stage pharmaceutical company dedicated to developing novel therapies for diseases with high unmet needs. They focus on innovative treatments in neurodegenerative diseases and metabolic disorders. Key products include AMX0035 for ALS and avexitide for post-bariatric hypoglycemia (PBH). The company is committed to delivering with speed and rigor.